The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

被引：0
|
作者：
C. J. Currie
C. D. Poole
E. A. M. Gale
机构：
[1] Cardiff University,School of Medicine
[2] The Pharma Research Centre,Department of Epidemiology
[3] Cardiff MediCentre,Diabetes and Metabolism, School of Medicine
[4] Pharmatelligence,undefined
[5] Bristol University,undefined
来源：
Diabetologia | 2009年 / 52卷
关键词：
Cancer; Insulin; Insulin analogues; Metformin; Sulfonylureas; Survival; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1766 / 1777
页数：11
相关论文
共 50 条
  • [1] The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
    Currie, C. J.
    Poole, C. D.
    Gale, E. A. M.
    [J]. DIABETOLOGIA, 2009, 52 (09) : 1766 - 1777
  • [2] The Influence of Type 2 Diabetes and Glucose-Lowering Therapies on Cancer Risk in the Taiwanese
    Hsieh, Ming-Chia
    Lee, Tzu-Chi
    Cheng, Shu-Min
    Tu, Shih-Te
    Yen, Ming-Hong
    Tseng, Chin-Hsiao
    [J]. EXPERIMENTAL DIABETES RESEARCH, 2012,
  • [3] The influence of glucose-lowering therapies on cancer specific mortality in type 2 diabetes
    Ioacara, S.
    Guja, C.
    Ionescu-Tirgoviste, C.
    Fica, S.
    Sabau, S.
    Radu, S.
    Anghel, M.
    Tiu, C.
    [J]. DIABETOLOGIA, 2011, 54 : S99 - S99
  • [4] Impact of glucose-lowering therapies on risk of stroke in type 2 diabetes
    Bonnet, F.
    Scheen, A. J.
    [J]. DIABETES & METABOLISM, 2017, 43 (04) : 299 - 313
  • [5] INFLUENCE OF GLUCOSE-LOWERING STRATEGIES ON FRACTURE RISK IN TYPE 2 DIABETES
    Gusova, A. A.
    Pavlova, M. G.
    Melnitchenko, G. A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S160 - S161
  • [6] Glucose-lowering therapies in type 2 diabetes: Opportunities and challenges for peptides
    Bailey, Clifford J.
    [J]. PEPTIDES, 2018, 100 : 9 - 17
  • [7] Newer Glucose-Lowering Therapies in Older Adults with Type 2 Diabetes
    Bilal, Anika
    Pratley, Richard E.
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (02) : 355 - 375
  • [8] Glucose-lowering therapies in patients with type 2 diabetes and cardiovascular diseases
    Prattichizzo, Francesco
    La Sala, Lucia
    Ryden, Lars
    Marx, Nikolaus
    Ferrini, Marc
    Valensi, Paul
    Ceriello, Antonio
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (2_SUPPL) : 73 - 80
  • [9] Glucose-lowering medicines for type 2 diabetes
    Davoren, Peter
    [J]. AUSTRALIAN FAMILY PHYSICIAN, 2015, 44 (05) : 272 - 276
  • [10] Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
    Kalyani, Rita R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (13): : 1248 - 1260
12345